Kazantseva, A.V.,
Davydova, Yu. D.,
Enikeeva, R.F.,
Mustafin, R.N.,
Lobaskova, M.M.,
Malykh, S.B.,
Khusnutdinova, E.K. (2022) .048; β = 0.063). The
data obtained confirm the involvement of TERT gene variants and age in telomere
ПРИМЕНЕНИЕ ГИБРИДНОГО ХИРУРГИЧЕСКОГО МЕТОДА В ЛЕЧЕНИИ ОСТРОГО ДЕСТРУКТИВНОГО ПИЕЛОНЕФРИТААнаньев, В.А.,
Павлов, В.Н.,
Пушкарёв, А.М.,
Ananev, V.A.,
Pavlov, V.N.,
Pushkarev, A.M. (2022) ) with bolus contrast before surgery and in the postoperative period with an assessment of laboratory
data Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) of the researched alleles were found with different frequencies among cases and controls; however, our
data indicate
Ahmad, S.,
Abbas, M.,
Ullah, M.F.,
Aziz, M.H.,
Beylerli, O.,
Alam, M.A.,
Syed, M.A.,
Uddin, S.,
Ahmad, A. (2022) factor has been a subject of interest for long time. Accumulating
data from in vitro as well as in vivo
Onorato, EM,
Alamanni, F,
Muratori, M,
Smolka, G,
Wojakowski, W,
Pysz, P,
Zorinas, A,
Zakarkaite, D,
Eltchaninoff, H,
Litzer, PY,
Godart, F,
Calvert, P,
Christou, C,
Mussayev, A,
Missiroli, B,
Buzaev, I,
Curello, S,
Tesorio, T,
Bartorelli, AL (2022) leaks (PVLs) were enrolled at 21 sites in 10 countries. Safety
data were available for 137 patients, who
Jiang, HP,
Zhang, DZ,
Aleksandrovich, KD,
Ye, JY,
Wang, LX,
Chen, XF,
Gao, M,
Wang, XZ,
Yan, T,
Yang, H,
Lu, EZ,
Liu, WW,
Zhang, C,
Wu, JN,
Yao, PL,
Sun, ZY,
Rong, X,
Timofeevich, SA,
Mahmutovich, SS,
Zheng, ZX,
Chen, X,
Zhao, SG (2022) /M phase cell cycle arrest. Clinical
data analysis revealed that RRM2 expression in glioma patients
МОРФОЛОГО-АНАТОМИЧЕСКИЕ ПРИЗНАКИ И ЧИСЛОВЫЕ ПОКАЗАТЕЛИ ЦВЕТКОВ БОЯРЫШНИКА КРУПНОКОЛЮЧКОВОГО (СRATAEGUS MACRACANTHA L.)Шубина, Т.В.,
Хасанова, С.Р.,
Кудашкина, Н.В.,
Shubina, T.V.,
Khasanova, S.R.,
Kudashkina, N.V. (2022) in hydrochloric acid 10% is 2,05±0,05%. The
data comply with the requirements of pharmacopoeial monograph 2
Xu, Dongxiao,
Zheng, Bingjie,
Wu, Qiaowei,
Yao, Jinbiao,
Ilyasova, Tatiana,
Beilerli, Aferinc,
Shi, Huaizhang (2022) for moyamoya disease from August 2019 to July 2021 were retrospectively reviewed. Clinical
data, including